Vyant Bio, Inc. 3 SEC Filings

Filed On	Filing
17 Nov 2021	Form 3: Fremeau Robert Thomas Jr., Chief Scientific Officer No securities owned
01 Apr 2021	Form 3: Yeh Yung-Ping, Director No securities owned
01 Apr 2021	Form 3: Boehm Marcus, Director No securities owned
01 Apr 2021	Form 3: Fletcher R John, Director No securities owned
01 Apr 2021	Form 3: Horobin Joanna, Director No securities owned
01 Apr 2021	Form 3: LaFrence Andrew D.c., Chief Financial Officer No securities owned
01 Apr 2021	Form 3: Hansen Paul R., Director No securities owned
14 Jan 2019	Form 3: Finger William Lansing, EVP Precision Medicine
06 Dec 2018	Form 3: Miles Michael Glenn, Chief Financial Officer
19 Jun 2018	Form 3: McCartney Michael Brian, Chief Commercial Officer No securities owned
28 Nov 2017	Form 3: Widmann Thomas F, Director No securities owned
24 Aug 2017	Form 3: Brandt Ralf, President, Discovery Services Holds 30,000 shares of Common Stock, par value $0.0001 per share
23 Feb 2017	Form 3: Gitelman Igor, Chief Accounting Officer No securities owned
12 Jul 2016	Form 3: Roberts John A, Chief Operating Officer No securities owned
09 Jul 2015	Form 3: Shaknovich Rita, VP of Hematopathology Services No securities owned
11 Jun 2015	Form 3: Hepburn Steven, VP of Biopharma Marketing No securities owned
11 Dec 2014	Form 3: McLeod Howard, Director No securities owned
10 Dec 2014	Form 3: Harris Geoffrey E., Director No securities owned
27 May 2014	Form 3: Welsh Michael J., Director Holds 5,000 shares of Common Stock, par value $0.0001 per share
01 Apr 2014	Form 3: Sitar Edward J, Chief Financial Officer No securities owned

Comments